Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.046 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.7 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |